April 3, 2025
Update: NBOs are due next week in the Clearwater-advised process for Minerva Imaging, a Denmark-based CRO and CDMO specializing in targeted radionuclide therapies, acc. to sources (NKP | M&A Insights Proprietary)
NKP | M&A Insights Proprietary
Headline from pre-deal coverage in M&A Insights